JP2009538318A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009538318A5 JP2009538318A5 JP2009512164A JP2009512164A JP2009538318A5 JP 2009538318 A5 JP2009538318 A5 JP 2009538318A5 JP 2009512164 A JP2009512164 A JP 2009512164A JP 2009512164 A JP2009512164 A JP 2009512164A JP 2009538318 A5 JP2009538318 A5 JP 2009538318A5
- Authority
- JP
- Japan
- Prior art keywords
- acceptable salt
- pharmaceutically acceptable
- dione
- amino
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80860206P | 2006-05-26 | 2006-05-26 | |
| PCT/US2007/012495 WO2007139939A2 (en) | 2006-05-26 | 2007-05-24 | Methods and compositions using immunomodulatory compounds in combination therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009538318A JP2009538318A (ja) | 2009-11-05 |
| JP2009538318A5 true JP2009538318A5 (cg-RX-API-DMAC7.html) | 2010-07-29 |
Family
ID=38606531
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009512164A Pending JP2009538318A (ja) | 2006-05-26 | 2007-05-24 | 併用療法において免疫調節化合物を用いる方法及び組成物 |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP2023912A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2009538318A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20090014393A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101495111A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2007267928A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2652888A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL195412A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2008014912A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2426542C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007139939A2 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200809956B (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101977603A (zh) * | 2008-01-29 | 2011-02-16 | 细胞基因公司 | 使用免疫调节化合物来调节cd59水平的方法 |
| WO2013142817A2 (en) * | 2012-03-23 | 2013-09-26 | Dennis Brown | Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo |
| EP3623011B1 (en) * | 2013-08-22 | 2025-02-12 | Vanda Pharmaceuticals Inc. | Trichostatin a for use in multiple myeloma treatment |
| JP2016528297A (ja) | 2013-08-22 | 2016-09-15 | ヴァンダ ファーマシューティカルズ インコーポレイテッド | 癌治療 |
| CN106455542A (zh) * | 2014-03-26 | 2017-02-22 | 布里格姆及妇女医院股份有限公司 | 用于人造血干/祖细胞的离体扩增的组合物和方法 |
| WO2015175916A1 (en) * | 2014-05-16 | 2015-11-19 | Celgene Corporation | Methods and compositions using 4-amino-2-(2,6 dioxo-piperidine-3-yl)-isoindoline-1,3-dione for treatment of cancers |
| EP4396331A1 (en) * | 2021-09-01 | 2024-07-10 | Flagship Pioneering Innovations VI, LLC | Methods and compositions for inducing fetal hemoglobin, modulating erythroid cell lineages, and perturbing megakaryocyte lineages |
| CN120129677A (zh) | 2022-11-04 | 2025-06-10 | 百时美施贵宝公司 | 化合物及其用于治疗血红素病变的用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5629327A (en) * | 1993-03-01 | 1997-05-13 | Childrens Hospital Medical Center Corp. | Methods and compositions for inhibition of angiogenesis |
| US7498171B2 (en) * | 2002-04-12 | 2009-03-03 | Anthrogenesis Corporation | Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
| DK1505973T3 (da) * | 2002-05-17 | 2010-05-31 | Celgene Corp | Kombinationer til behandling af multipelt myelom |
| KR20050057672A (ko) * | 2002-10-24 | 2005-06-16 | 셀진 코포레이션 | 통증의 치료, 변형 및 관리를 위한 면역조절 화합물을포함하는 조성물 및 이의 사용 방법 |
| US7563810B2 (en) * | 2002-11-06 | 2009-07-21 | Celgene Corporation | Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases |
| US20050043233A1 (en) * | 2003-04-29 | 2005-02-24 | Boehringer Ingelheim International Gmbh | Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis |
| BRPI0417186A (pt) * | 2003-12-02 | 2007-03-06 | Celgene Corp | método de tratamento de um indivìduo tendo uma hemoglobinopatia ou uma anemia, de modulação da diferenciação de uma célula-tronco ou precursora de cd34+ para uma linhagem de eritróides, e, composição farmacêutica |
| US20060058311A1 (en) * | 2004-08-14 | 2006-03-16 | Boehringer Ingelheim International Gmbh | Combinations for the treatment of diseases involving cell proliferation |
-
2007
- 2007-05-24 KR KR1020087031357A patent/KR20090014393A/ko not_active Withdrawn
- 2007-05-24 MX MX2008014912A patent/MX2008014912A/es not_active Application Discontinuation
- 2007-05-24 EP EP07795353A patent/EP2023912A2/en not_active Withdrawn
- 2007-05-24 WO PCT/US2007/012495 patent/WO2007139939A2/en not_active Ceased
- 2007-05-24 RU RU2008151713/15A patent/RU2426542C2/ru not_active IP Right Cessation
- 2007-05-24 CN CNA2007800277224A patent/CN101495111A/zh active Pending
- 2007-05-24 ZA ZA200809956A patent/ZA200809956B/xx unknown
- 2007-05-24 CA CA002652888A patent/CA2652888A1/en not_active Abandoned
- 2007-05-24 JP JP2009512164A patent/JP2009538318A/ja active Pending
- 2007-05-24 AU AU2007267928A patent/AU2007267928A1/en not_active Abandoned
-
2008
- 2008-11-20 IL IL195412A patent/IL195412A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Pusic et al. | Update on clinical experience with AMD3100, an SDF-1/CXCL12–CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells | |
| KR100711181B1 (ko) | 골수형성이상 증후군의 치료 및 관리를 위한 면역조절화합물의 사용 방법 및 이를 포함하는 조성물 | |
| KR101483802B1 (ko) | 외투층 세포 림프종의 치료에 있어서 3-(4-아미노-1-옥소-1,3-디히드로-이소인돌-2-일)-피페리딘-2,6-디온의 용도 | |
| JP4865027B2 (ja) | 抗エストロゲン剤とファルネシルプロテイントランスフェラーゼ阻害剤の組み合わせ物 | |
| US20050143420A1 (en) | Methods and compositions for the treatment and management of hemoglobinopathy and anemia | |
| EP1267848A1 (en) | Dosing regimen comprising a farnesyl protein transferase inhibitor for the treatment of cancer | |
| KR20140008282A (ko) | 혈액암의 치료 | |
| CN103025330A (zh) | 使用来那度胺和阿扎胞苷的组合疗法治疗骨髓增生异常综合症的方法 | |
| US20080051431A1 (en) | Methods and compositions using immunomodulatory compounds in combination therapy | |
| CA2672000A1 (en) | Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of lymphoma | |
| WO2001064246A2 (en) | Farnesyl protein transferase inhibitor combinations with an her2 antibody | |
| JP2013231086A (ja) | 化学療法の強化方法 | |
| JP2006503866A (ja) | 癌を処置するための相乗的な方法および組成物 | |
| US10752612B2 (en) | PLK4 inhibitors | |
| RU2008151713A (ru) | Способы и композиции с применением иммуномодулирующих соединений при комбинированном лечении | |
| WO2017042944A1 (ja) | フィラデルフィア染色体陽性(Ph+)急性リンパ性白血病(ALL)の治療薬又は治療方法 | |
| EP1261348A2 (en) | Combinations of a farnesyl protein transferase inhibitor with nitrogen mustard or nitrosourea alkylating agents | |
| JP2009545620A5 (cg-RX-API-DMAC7.html) | ||
| WO2010123049A1 (ja) | 癌治療のための選択的ep4受容体拮抗物質 | |
| AU2017300738A1 (en) | Combination of a BCL-2 inhibitor and a MCL-1 inhibitor, uses and pharmaceutical compositions thereof | |
| Annageldiyev et al. | The PI3K/AKT pathway inhibitor ISC-4 induces apoptosis and inhibits growth of leukemia in preclinical models of acute myeloid leukemia | |
| US20030181473A1 (en) | Farnesyl protein transferase inhibitor combinations with taxane compounds | |
| EP1261343A2 (en) | Farnesyl protein transferase inhibitor combinations with anti-tumor nucleoside derivatives | |
| WO2001064218A2 (en) | Farnesyl protein transferase inhibitor combinations | |
| WO2001064197A2 (en) | Farnesyl protein transferase inhibitor combinations with anti-tumor anthracycline derivatives |